Catalyst Wire Dossier Catalyst Wire Dossier

Pitavastatin/Fenofibrate

pitavastatin/fenofibrate · Hanlim Pharm. Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pitavastatin/Fenofibrate, covering 2018-08-07 to 2018-08-07. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia [Phase 3]

See pricing